Balance Sheet Data
ReShape Lifesciences Inc. (RSLS)
$0.8
+0.01 (+1.28%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 10.16 | 5.55 | 2.94 | 2.96 | 22.77 | 355.79 | 2,427.76 | 16,565.84 | 113,037.10 | 771,309.50 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.49 | 0.92 | 4.10 | 2.62 | 2.81 | 48.28 | 329.41 | 2,247.71 | 15,337.28 | 104,654.01 |
| Account Receivables (%) | ||||||||||
| Inventories | 2.82 | 0.98 | 1.32 | 2.24 | 3 | 80.15 | 546.90 | 3,731.77 | 25,463.77 | 173,752.21 |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.09 | 1.63 | 4.26 | 3.65 | 3.47 | 81.43 | 555.64 | 3,791.41 | 25,870.71 | 176,529.01 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.14 | -0.05 | -0.01 | -0.39 | -0.35 | -4.63 | -31.61 | -215.67 | -1,471.64 | -10,041.77 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.